Dynorphinergic Mechanism Mediating Endomorphin-2-Induced Antianalgesia in the Mouse Spinal Cord

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 3, 2003, Pages 1135-1141

  Wu, Hsiang En ^a   Sun, Han Sen ^a   Darpolar, Moses ^a   Leitermann, Randy J ^a   Kampine, John P ^a   Tseng, Leon F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ANALGESIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA ENDORPHIN; BETA FUNALTREXAMINE; DELTORPHIN; DIZOCILPINE; DYNORPHIN A; ENDOMORPHIN 2; KAPPA OPIATE RECEPTOR AGONIST; METENKEPHALIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CROSS TOLERANCE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BLOCKING; SPINAL CORD; STIMULUS RESPONSE;

ANALGESICS, OPIOID; ANIMALS; ANTIBODIES, BLOCKING; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNORPHINS; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, SPINAL; MALE; MICE; MORPHINE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PAIN MEASUREMENT; REACTION TIME; RECEPTORS, OPIOID; SPINAL CORD;

EID: 0344304775     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.056242     Document Type: Article

References (38)

1. Aksu F, Holmes BB, and Fujimoto JM (1993) Opioid antagonists: indirect antagonism of morphine analgesia by spinal dynorphin A. Pharmacol Biochem Behav 45:409-418.
2. Arts KS, Fujimoto JM, and Tseng LF (1992) Involvement of dynorphin A and not substance P in the spinal antianalgesia action of capsaicin against morphine-induced antinociception in mice. J Pharamcol Exp Ther 261:643-651.
3. D'Amour FE and Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79.
4. Fujimoto JM, Arts KS, Rady JJ, and Tseng LF (1990) Spinal dynorphin A (1-17): possible mediator of antianalgesic action. Neuropharmacology 29:609-617.
5. Gardell LR, Burgess SE, Dogrul A, Ossipov MH, Malan TP, Lai J, and Porreca F (2002) Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance. Pain 98:79-88.
6. Goldberg IE, Rossi GC, Letchworth SR, Mathis JP, Ryan-Moro J, Leventhal L, Su W, Emmel D, Bolan EA, and Pasternak GW (1998) Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J Pharmacol Exp Ther 286:1007-1013.
7. Holmes BB and Fujimoto JM (1992) Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17). J Pharmacol Exp Ther 261:146-152.
8. Holmes BB and Fujimoto JM (1993) Inhibiting a spinal dynorphin A component enhances intrathecal morphine antinociception in mice. Anesth Analg 77:1166-1173.
9. Hung K, Wu H, Mizoguchi H, and Tseng LF (2002) Acute antinociceptive tolerance and unidirectional cross-tolerance to endomorphin-1 and endomorphin-2 given intraventricularly in the rat. Eur J Pharmacol 448:169-174.
10. Hylden JLK and Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 167:313-316.
11. Laughlin TM, Vanderah TW, Lashbrook J, Nichols ML, Ossipov M, Porreca F, and Wilcox GL (1997) Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain 72:253-260.
12. Leitermann RJ, Terashvili M, Mizoguchi H, Chen F, Clithero A, and Tseng LF (2003) Release of immunoreactive dynorphin A(1-17) from the spinal cord by intrathecal perfusion of endomorphin-2, but not endomorphin-1 in anesthetized rats. Soc Neurosci Abstr 33:908.12.
13. McNally GP (1999) Pain facilitatory circuits in the mammalian central nervous system: their behavioral significance and role in morphine analgesic tolerance. Neurosci Biobehav Rev 23:1059-1078.
14. Millan MJ (1999) The induction of pain: an integrative review. Prog Neurobiol 57:1-164.
15. Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355-474.
16. Mizoguchi H, Narita M, Nagase H, and Tseng LF (1995) Antisense oligodeoxynucleotide to a δ-opioid receptor blocks the antinociception induced by cold water swimming. Regul Pept 59:255-259.
17. Monory K, Bourin M-C, Spetea M, Tomooly C, Toth G, Matthes HW, Kieffer BL, Hanoune J, and Borsodi A (2000) Specific activation of the μ opioid receptor (MOR) by endomorphin 1 and endomorphin 2. Eur J Neurosci 22:577-584.
18. Narita M, Mizoguchi H, Narita M, Dun NJ, Hwang BH, Endoh T, Suzuki T, Nagase H, Suzuki T, and Tseng LF (2000) G protein activation by endomorphins in the mouse periaqueductal gray matter. J Biomed Sci 7:221-225.
19. 35S]GTPγ S binding in the mouse spinal cord. Eur J Pharmacol 351:383-387.
20. Ohsawa M, Mizoguchi H, Narita M, Nagase H, Kampine JP, and Tseng LF (2001) Different antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 298:592-597.
21. Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16:1-18.
22. Pick CG, Paul D, and Pasternak GW (1991) Comparison of naloxonazine and beta-funaltrexamine antagonism of μ1 and μ2 opioid actions. Life Sci 48:2005-2011.
23. Rady JJ, Fujimoto JM, and Tseng LF (1991) Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors. J Pharmacol Exp Ther 259:1073-1080.
24. Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A, Sakurada C, Takeshita M, Zadina JE, Kastin AJ, et al. (2000) Different antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Brain Res 881:1-8.
25. Sakurada S, Hayashi T, Yuhki M, Orito T, Zadina JE, Kastin AJ, Fujimura T, Murayama K, Sakurada C, Sakurada T, et al. (2001) Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur J Pharmacol 427:203-210.
26. Singh L, Oles RJ, Field MJ, Atwal P, Woodruff GN, and Hunter JC (1996) Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine. Br J Pharmacol 118:1317-1325.
27. Tang Q, Lynch RM, Porreca F, and Lai J (2000) Dynorphin A elicits an increase in intracellular calcium in cultured neurons via a non-opioid, non-NMDA mechanism. J Neurophysiol 83:2610-2615.
28. Tseng LF and Collin KA (1993) Spinal involvement of both dynorphin A and met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse. J Pharmacol Exp Ther 266: 1430-1438.
29. 5]enkephalin and cholecystokinin from the spinal cord by β-endorphin administered intraventricularly in the pentobarbital-anesthetized rat. Eur J Pharmacol 215:309-312.
30. Tseng LF, Narita M, Mizoguchi H, Kawai K, Mizusuna A, Kamei J, Suzuki T, and Nagase H (1997) Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-) TAN-67, in the mouse spinal cord. J Pharmacol Exp Ther 280:600-605.
31. Tseng LF, Narita M, Suganuma C, Mizoguchi H, Ohsawa M, Nagase H, and Kampine JP (2000) Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 292:576-583.
32. Vanderah TW, Laughlin T, Lashbrook JM, Nichols ML, Wilcox GL, Ossipov MH, Malan TP, and Porreca F (1996) Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain 68:275-281.
33. Wang Z, Gardell LR, Ossipov HM, Vanderah TW, Brennan MB, Hochgeschwender U, Hruby VJ, Malan TP Jr, Lai J, and Porreca F (2001) Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci 21:1779-1786.
34. Wu H, Hung K, Mizoguchi H, Fujimoto JM, and Tseng LF (2001) Acute antinociceptive tolerance and asymmetric cross-tolerance between endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse. J Pharmacol Exp Ther 299:1120-1125.
35. Wu H, Hung K, Mizoguchi H, Nagase H, and Tseng LF (2002a) Roles of endogenous opioid peptides in modulation of nocifensive response to formalin. J Pharmacol Exp Ther 300:647-654.
36. Wu H, Mizoguchi H, Terashvili M, Leitermann RJ, Hung K, Fujimoto JM, and Tseng LF (2002b) Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of μ-opioid receptor clone leads to differential loss of spinal endomorphin-1- and endomorphin-2-induced antinociception in the mouse. J Pharmacol Exp Ther 303:867-873.
37. Xu JY and Tseng LF (1997) [Met]enkephalin in the spinal cord is involved in the antinociception induced by intracerebroventricularly-administered etorphine in the mouse. Neuroscience 80:579-585.
38. Zadina JE, Hackler L, Ge L-J, and Kastin AJ (1997) A potent and selective endogenous agonist for the μ-opioid receptor. Nature (Lond) 386:499-502.